Biora Therapeutics Inc

NASDAQ:BIORUnited States

NASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)

08:13 AM EST, 11/14/2024 (MT Newswires) -- ...

current assets 1,990 3,030 ----------- ---------- Total current assets 6,054 19,071 Property and equipment, net 1,175 1,156 Right-of-use assets 1,011 1,614 Other assets 193 3,302 Goodwill 6,072 6,072 ----------- ---------- Total assets $ 14,505 $ 31,215 =========== ========== Liabilities and Stockholders' Deficit Current liabilities: Accounts payable $ 6,916 $ 2,843 Accrued expenses and other current liabilities 21,404 17,319 Warrant liabilities 18,688 40,834 Convertible notes, net 4,527 -- Senior secured convertible notes, net 14,344 -- Related party senior secured convertible notes, net - current portion 19,721 1,976 Derivative liabilities 35,018 -- ----------- ---------- Total current liabilities 120,618 62,972 Convertible notes, net -- 9,966 Senior secured convertible notes, net -- 14,591 Related party senior secured convertible notes, net -- 19,179 Derivative liabilities -- 22,899 Other long-term liabilities 516 3,029 ----------- ---------- Total liabilities $ 121,134 $ 132,636 ----------- ---------- Stockholders' deficit: Common stock 3 2 Additional paid-in capital 879,530 868,613 Accumulated deficit (967,084) (950,958) Treasury stock (19,078) (19,078) ----------- ---------- Total stockholders' deficit (106,629) (101,421) ----------- ---------- Total liabilities and stockholders' deficit $ 14,505 $ 31,215 =========== ========== (1) The condensed consolidated balance sheet data as of December 31, 2023 has been derived from the audited consolidated financial statements